שווי כולל של החברה: Tivic Health Corp (TIVC)

Tivic Health Systems (TIVC) holds a leading position in bioelectronics, offering the ClearUP drug-free solution for treating allergies and sinusitis. However, aggressive marketing is creating a financial imbalance where expenses exceed revenues, depleting capital. The current Separate Enterprise Value stands at 0.58. The price chart below accounts for risks regarding Asian chip supply chain disruptions and US trade barriers.

Tivic Health Systems (TIVC) is developing an innovative standard for drug-free allergy therapy, transforming the ClearUP device into an indispensable element of daily user comfort. The enterprise value trend reflects the actual acquisition price of the business, summing market capitalization and net debt to assess the company's true scale. It is critical for investors to monitor this chart to distinguish the fundamental growth of the ecosystem's maturity from market overheating and potential correction risks.